Andre Pierre Louis

Array ( [id] => 4269121 [patent_doc_number] => 06322965 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => 'Chimera antigen peptide' [patent_app_type] => 1 [patent_app_number] => 9/020846 [patent_app_country] => US [patent_app_date] => 1998-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14634 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 225 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/322/06322965.pdf [firstpage_image] =>[orig_patent_app_number] => 020846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4210238 [patent_doc_number] => 06086901 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Use of microparticles combined with submicron oil-in-water emulsions' [patent_app_type] => 1 [patent_app_number] => 9/015736 [patent_app_country] => US [patent_app_date] => 1998-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9821 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/086/06086901.pdf [firstpage_image] =>[orig_patent_app_number] => 015736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4126127 [patent_doc_number] => 06146629 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'Human monoclonal antibody against Hepatitis B virus surface antigen (HBVsAg)' [patent_app_type] => 1 [patent_app_number] => 9/000088 [patent_app_country] => US [patent_app_date] => 1998-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 5296 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/146/06146629.pdf [firstpage_image] =>[orig_patent_app_number] => 000088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4184476 [patent_doc_number] => 06093535 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-25 [patent_title] => 'Method for identifying attenuated chickenpox virus Oka strain or strain originating therein and acceptable as attenuated chickenpox vaccine virus' [patent_app_type] => 1 [patent_app_number] => 8/983045 [patent_app_country] => US [patent_app_date] => 1998-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 2 [patent_no_of_words] => 9697 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/093/06093535.pdf [firstpage_image] =>[orig_patent_app_number] => 983045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1505981 [patent_doc_number] => 06440422 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Recombinant MVA virus, and the use thereof' [patent_app_type] => B1 [patent_app_number] => 09/002443 [patent_app_country] => US [patent_app_date] => 1998-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8577 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440422.pdf [firstpage_image] =>[orig_patent_app_number] => 09002443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4173891 [patent_doc_number] => 06036959 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'HCMV/HSV fusion glycoproteins' [patent_app_type] => 1 [patent_app_number] => 8/997211 [patent_app_country] => US [patent_app_date] => 1997-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 4871 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/036/06036959.pdf [firstpage_image] =>[orig_patent_app_number] => 997211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4141292 [patent_doc_number] => 06063384 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'Encapsidated recombinant viral nucleic acid and methods of making and using same' [patent_app_type] => 1 [patent_app_number] => 8/987867 [patent_app_country] => US [patent_app_date] => 1997-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 58 [patent_no_of_words] => 34377 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063384.pdf [firstpage_image] =>[orig_patent_app_number] => 987867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 553656 [patent_doc_number] => 07157089 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-01-02 [patent_title] => 'Immune responses using compositions containing stress proteins' [patent_app_type] => utility [patent_app_number] => 08/977787 [patent_app_country] => US [patent_app_date] => 1997-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 14247 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/157/07157089.pdf [firstpage_image] =>[orig_patent_app_number] => 08977787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1308121 [patent_doc_number] => 06613333 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-02 [patent_title] => 'Immunodominant human T-cell epitopes of hepatitis C virus' [patent_app_type] => B1 [patent_app_number] => 08/974690 [patent_app_country] => US [patent_app_date] => 1997-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 53538 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/613/06613333.pdf [firstpage_image] =>[orig_patent_app_number] => 08974690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1234542 [patent_doc_number] => 06689368 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-10 [patent_title] => 'Immunodominant human T-cell epitopes of hepatitis C virus' [patent_app_type] => B1 [patent_app_number] => 08/974685 [patent_app_country] => US [patent_app_date] => 1997-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 27423 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689368.pdf [firstpage_image] =>[orig_patent_app_number] => 08974685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3928665 [patent_doc_number] => 05972346 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Hepatitis B vaccine' [patent_app_type] => 1 [patent_app_number] => 8/894643 [patent_app_country] => US [patent_app_date] => 1997-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3315 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972346.pdf [firstpage_image] =>[orig_patent_app_number] => 894643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4094340 [patent_doc_number] => 06048538 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-11 [patent_title] => 'Peptides derived from the non-structural proteins of foot and mouth disease virus as diagnostic reagents' [patent_app_type] => 1 [patent_app_number] => 8/943173 [patent_app_country] => US [patent_app_date] => 1997-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 9627 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/048/06048538.pdf [firstpage_image] =>[orig_patent_app_number] => 943173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4418647 [patent_doc_number] => 06177241 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'Use of peptides to improve specificity of an immunoassay for the detection of cytomegalovirus specific IgM antibody' [patent_app_type] => 1 [patent_app_number] => 8/935009 [patent_app_country] => US [patent_app_date] => 1997-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 22 [patent_no_of_words] => 19094 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177241.pdf [firstpage_image] =>[orig_patent_app_number] => 935009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3930653 [patent_doc_number] => 05980901 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Viral defective interfering particles and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/933480 [patent_app_country] => US [patent_app_date] => 1997-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 30 [patent_no_of_words] => 15236 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/980/05980901.pdf [firstpage_image] =>[orig_patent_app_number] => 933480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3975299 [patent_doc_number] => 05904942 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-18 [patent_title] => 'Fermented formula feed, its production, and uses' [patent_app_type] => 1 [patent_app_number] => 8/927809 [patent_app_country] => US [patent_app_date] => 1997-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4549 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/904/05904942.pdf [firstpage_image] =>[orig_patent_app_number] => 927809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4233145 [patent_doc_number] => 06090416 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'Fermented formula feed, its production, and uses' [patent_app_type] => 1 [patent_app_number] => 8/927816 [patent_app_country] => US [patent_app_date] => 1997-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4552 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090416.pdf [firstpage_image] =>[orig_patent_app_number] => 927816 [rel_patent_id] =>[rel_patent_doc_number] =>)